A detailed history of Sapient Capital LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Sapient Capital LLC holds 5,260 shares of BDX stock, worth $1.19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
5,260
Previous 5,264 0.08%
Holding current value
$1.19 Million
Previous $1.23 Million 3.09%
% of portfolio
0.03%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$221.47 - $242.41 $885 - $969
-4 Reduced 0.08%
5,260 $1.27 Million
Q2 2024

Jul 15, 2024

BUY
$225.07 - $246.17 $4,276 - $4,677
19 Added 0.36%
5,264 $1.23 Million
Q1 2024

Apr 22, 2024

SELL
$233.45 - $247.73 $1,400 - $1,486
-6 Reduced 0.11%
5,245 $1.3 Billion
Q4 2023

Feb 06, 2024

SELL
$232.24 - $267.23 $14,398 - $16,568
-62 Reduced 1.17%
5,251 $1.28 Billion
Q4 2023

Jan 29, 2024

BUY
$232.24 - $267.23 $1.23 Million - $1.42 Million
5,313 New
5,313 $1.3 Billion

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.